A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
Status:
Suspended
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy and safety of Toripalimab injection
(JS001) given before and after concurrent chemoradiotherapy for locally advanced esophageal
squamous cell carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Collaborators:
Shanghai Junshi Bioscience Co., Ltd. TopAlliance Biosciences, Inc.